Prompt evaluation by an ophthalmologist can determine if NAION or another eye condition is present
Nonetheless, further large-scale, long-term clinical trials are warranted to standardize intermittent fasting protocols, clarify optimal fasting regimens, and evaluate sustained outcomes across different populations
SOLIQUA 100/33 is not recommended in patients with severe gastroparesis
Eating something small before or after your injection can take the edge off
The class of medications called glucagon-like peptide-1 receptor agonists (GLP-1RAs) was first authorized in the early 2000s and includes semaglutide, which gained Food and Drug Administration (FDA) approval in 2017 for patients with Type 2 diabetes

Erythropoietic Protoporphyria (EPP) Melanotan-1 Melanotan-1 (afamelanotide/Scenesse) is the only EMA-approved treatment for EPP, with Phase 3 RCT data showing increased pain-free sun exposure and improved quality of life Vitiligo Adjunct Therapy Melanotan-1 Small RCT data shows faster and deeper repigmentation when afamelanotide implants are combined with NB-UVB phototherapy compared to phototherapy alone Photoprotection Research Melanotan-1 Melanotan-1 enhances eumelanin production and DNA repair mechanisms with a favorable safety profile established across multiple clinical trials Melanocortin Receptor Pharmacology Melanotan-2 Melanotan-2 nonselective receptor profile makes it a useful research tool for studying MC1R through MC5R signaling pathways Sexual Dysfunction Research Melanotan-2 Melanotan-2 MC4R activation produces erectogenic effects